Cantor Fitzgerald, L. P. Enochian Biosciences Inc Transaction History

Cantor Fitzgerald, L. P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.03 - $2.13 $14,228 - $29,423	13,814 Added 30.09%	59,724 $61,000
Q2 2022 Aug 15, 2022	BUY	$1.93 - $8.73 $16,231 - $73,419	8,410 Added 22.43%	45,910 $89,000
Q1 2022 May 16, 2022	BUY	$4.42 - $9.0 $165,750 - $337,500	37,500 New	37,500 $309,000

14M

33.7K

Ticker ENOB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,950,000
Market Cap $244M
Description
Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...

Get notified when there are updates to the investment portfolio of Cantor Fitzgerald, L. P., based on Form 13F filings with the SEC.

Stay updated on Cantor Fitzgerald, L. P. with notifications on news.